Based on the experimental data, we identified the novel mechanism of ATF4-mediated macrophage polarization and inflammation in the pathogenesis of AAA development, which would provide a potential therapeutic target for the prevention and treatment of AAA. The gene discussed is ATF4; the disease is triple-A syndrome.